Avella Specialty Pharmacy Sold to OptumRx

We provided healthcare regulatory and antitrust counsel to Avella Specialty Pharmacy (owned by Riordan, Lewis & Haden) in its sale to OptumRx (owned by United Health Group, Inc. (Nasdaq: UNH). Terms of the transaction were not publicly disclosed.

Avella is a national specialty pharmacy recognized for its deep clinical knowledge & customer service serving patients in all 50 states.

OptumRx is a pharmacy care services company helping clients and more than 65 million members achieve better health outcomes and lower overall costs through innovative prescription drug benefit services and is part of Optum®, a leading information and technology-enabled health services business dedicated to making the health system work better for everyone.

You Also May Be Interested In:

  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company
  • We represented Verdi Oncology, Inc. in its acquisition of NexGen Oncology. With the acquisition of NexGen, Verdi has launched Verdi...
    Client Type: Private Company
  • Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee

    We served as lead counsel to BriovaRx Infusion Services (BriovaRx) in obtaining a Certificate of Need (CON) to expand its...
    Client Type: Private Company